Company Overview of X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. was acquired by Exelixis, Inc. X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors. The company offers drug discovery platform for the nuclear receptor gene family; and drug candidates to treat cardiovascular and metabolic disorders. The company was incorporated in 1999 and is based in San Diego, California.
4757 Nexus Centre Drive
San Diego, CA 92121
Founded in 1999
Key Executives for X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact X-Ceptor Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.